Ascentage Pharma Group International (AAPG) stock
AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.14−0.15 (-1.13%)
Close on Nov 17, 2026Market cap $1.23BP/E –Yield –
Ascentage Pharma Group International ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Ascentage Pharma Group International
Ascentage Pharma Group International has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?